News
Opinion
Why it’s easier to be prescribed an opioid painkiller than the treatment for opioid addictionPrescription opioid abuse and its downstream effects have reached epidemic proportions in the United States. On May 26, the Food and Drug Administration (FDA) moved a step closer to providing help to ...
Iowa could receive up to $5.4 million in opioid settlement funds after opioid makers settled a lawsuit with attorneys general ...
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine ...
Get the facts on cost and buprenorphine, how generics compare with brand names, what financial assistance may be available, and more.
Buprenorphine linked to reduced rate of adverse outcomes, including severe maternal morbidity, NICU admissions, and preterm births.
Objectives To describe the effect of in utero exposure to the buprenorphine+naloxone combination product in a rural and remote population. Setting A district hospital that services rural and remote, ...
For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable.
Widespread integration of buprenorphine treatment into primary care could also greatly increase its accessibility and has been demonstrated to increase treatment retention in pilot studies.
Patients were randomized at a 2:1 ratio to rapid initiation [received a single dose of 4 mg transmucosal buprenorphine (TM-BUP), followed by a SUBLOCADE injection within one hour] or to a standard ...
What to Know About Buprenorphine, a Proven Treatment for Opioid Addiction This medicine may be one of the best tools doctors have to fight the fentanyl crisis.
We aim to compare the effectiveness of a high (24 mg) vs standard (16 mg) maintenance daily dose of buprenorphine for improving retention in treatment, decreasing the use of non-prescribed opioids, ...
SAN ANTONIO — Treatment with once-weekly semaglutide 2.4 mg (Wegovy) significantly reduced hospital admissions for all causes — not just cardiac — and overall hospitalization time in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results